UK Startup Funding Report: £2978.4m raised across AI, Healthtech and Energy (31 Aug–4 Sept 2026).
It's Friday, 4 September, and this is your UK Startup Funding Report.
This week saw a string of large growth rounds and early-stage raises across AI, healthtech and energy. Total disclosed UK-linked funding came to £2,978.4m between 31 Aug and 4 Sept 2026.
AI infrastructure and governance
This week investors doubled down on the foundations that let enterprises run models at scale, from debt packages for large hardware campuses to seed rounds for observability and orchestration software. The flow of capital underlines a bifurcated market: heavy investment in compute capacity sits alongside early‑stage bets on governance and safe operation.
Leading the headlines, Nscale secured a roughly £2.22 billion senior secured loan arranged by J.P. Morgan and Goldman Sachs to fund GPU infrastructure, two AI campuses and the liquid‑cooling and site build‑out required for high‑density compute. At the other end of the spectrum, AI Score raised £3.99 million in a seed round led by Fuel Ventures to expand an observability and governance platform, Pharosyn took £2.22 million in seed funding led by Moonfire to embed models into pharma decision workflows, and Orchestra raised £2.4 million to launch a control plane for data and AI orchestration.
Taken together, the deals show how investors are financing both the physical backbones of compute and the software that makes those systems auditable and usable. Large tickets are flowing to capacity; early‑stage equity is backing the tooling that enterprises will need to control, govern and monetise that capacity — though how some seed companies scale into enterprise sales remains an open question.
This week's AI & Data Infrastructure deals:
Nscale closed roughly £2.218bn in large senior secured loan facilities arranged by J.P. Morgan and Goldman Sachs to fund GPU infrastructure and two AI campuses. The debt-backed package is earmarked for hardware, liquid cooling and site build‑out to support high-density AI compute.
AI Score raised £3.99m in a seed round led by Fuel Ventures to expand its observability and governance platform for generative and agentic AI. The product maps AI assets and usage to help compliance and risk teams maintain audit trails as deployments scale.
Pharosyn raised £2.22m in a seed round led by Moonfire to build AI infrastructure for commercial decision‑making in pharmaceutical companies. The platform aims to embed models and workflows into portfolio and forecasting processes to speed strategic analysis.
Orchestra raised £2.4m to launch a control plane for data and AI workflow orchestration that reduces pipeline costs and speeds delivery. The funding will expand engineering and go‑to‑market efforts as the company targets enterprise deployments.
Healthtech and biotech: platforms meet clinical validation
Funding this week emphasised scalable clinical networks, AR‑backed rehabilitation and the early steps of university spinouts. Investors placed capital into platforms intended to speed diagnostics and trials, and into companies working to build clinical evidence for immersive therapy — a combination that reflects a market balancing infrastructure with clinical validation.
Notable rounds included Scan.com, which raised £165 million in combined equity and debt to scale an API and AI routing network for medical imaging, onboard more providers and pursue M&A while automating scheduling and routing reports to subspecialist radiologists. Strolll secured £4.3 million from Innovate UK and private investors to fund clinical validation of AR‑delivered neurorehabilitation and to outfit a biomechanics lab. Healome Therapeutics announced a pre‑seed round tied to university research but did not disclose terms, signalling an early move towards commercialisation, while Healf took a minority growth investment led by SEMCAP Beauty & Wellness to support product development and international expansion.
The pattern is familiar: larger rounds aim to build interoperable networks and routable clinical workflows, while smaller grants and early equity de‑risk clinical validation. Which companies will convert trials into broad commercial adoption remains to be seen, but the mix of public support and strategic growth capital is clear.
This week's Healthtech & Biotech deals:
Scan.com raised £165m in combined equity and debt to scale its API and AI routing network for medical imaging, accelerate provider onboarding and pursue M&A. The capital is intended to expand a searchable imaging network that automates scheduling and routes reports to subspecialist radiologists.
Strolll secured £4.3m from Innovate UK and private investors to fund clinical validation and product development for AR-delivered neurorehabilitation. The package will support a biomechanics lab and trials aimed at shortening clinical validation timelines.
Healome Therapeutics announced a pre‑seed round to commercialise university‑linked research but did not disclose the amount or investors. The brief announcement signals an early step toward translating academic work into a healthtech venture.
Healf secured an undisclosed minority growth investment led by SEMCAP Beauty & Wellness to support product development and international expansion. The company says the capital will help scale its personalised wellbeing platform across Europe.
Greentech and mobility: pilots, supply chain and pragmatic funding
Investors this week backed both upstream materials and practical software as decarbonisation moves from laboratory research to pilot projects and scale‑up. Public and strategic capital supported battery supply‑chain plays, while smaller rounds targeted pilots for synthetic fuels, water‑treatment materials and EV charging payments, illustrating a pragmatic approach to green investment.
Nexeon closed a £100 million round that included a £52.6 million commitment from the National Wealth Fund to support UK pilot manufacturing of silicon‑carbon anode materials and shore up the domestic battery supply chain. Ki 13 raised £3.7 million in seed funding to pilot a biomass electrolysis process for hydrogen and biogenic CO2 separation toward synthetic fuels. Pure Capture Innovations took £530,000 in pre‑seed funding, supported by SFC Capital and Carbon13, to develop carbon‑based adsorbents for PFAS and micropollutant removal, while Rightcharge raised £500,000 to build payments and reimbursement functionality for fleet EV charging and expand into Europe.
The week underlines investor preference for projects that can demonstrate tangible pilot results or regulatory alignment, and for software that reduces barriers to EV adoption. Blended public and private funding continues to be important for capital‑intensive scale‑up efforts.
This week's Energy & Greentech / Mobility deals:
Nexeon closed a £100m round, including a £52.6m commitment from the National Wealth Fund, to support UK pilot manufacturing of silicon‑carbon anode materials and strengthen the domestic battery supply chain. The funding blends public and strategic investors to hasten commercial scale‑up.
Ki 13 raised £3.7m in seed funding to pilot a biomass electrolysis process that separates hydrogen and biogenic CO2 for synthetic fuels. The money will fund an industrial pilot and move the technology toward commercial demonstration.
Pure Capture raised £530k in a pre‑seed round with support from SFC Capital and Carbon13 to develop carbon‑based adsorbents for PFAS and micropollutant removal. The funds will advance material validation and on‑site testing for water treatment applications.
Rightcharge raised £500k in a pre‑seed round to develop its payments and reimbursement platform for fleet EV charging and to expand into Europe. The product automates home‑charging reimbursements and gives fleets visibility over costs and emissions.
Enterprise SaaS: transactional tools becoming continuous platforms
Investors this week placed sizeable bets on vendors turning transactional tools into continuous platforms by layering data and AI on top of existing workflows. The playbook is to surface people or property insights across systems and then monetise the ongoing relationship rather than a one‑off sale.
HiBob raised £122.56 million in a round led by Salesforce to build an organisational intelligence layer and make workforce context available to AI‑driven workflows. Reapit secured over £20 million from Accel KKR to accelerate AI and consumer‑facing features on its property platform and to move estate agents toward continual customer engagement via the Reapit Home portal. needi closed a £1 million pre‑seed from IFNI to scale a personalised corporate gifting and onboarding platform and support international sales.
The investment pattern favours platforms that can stitch data into daily operations and deliver recurring value. Whether these vendors accelerate enterprise adoption will depend on their ability to integrate with legacy systems and demonstrate clear ROI.
This week's Enterprise & Vertical SaaS (Proptech, HRTech, Commerce) deals:
HiBob raised £122.56m in a round led by Salesforce to build its organisational intelligence layer and make workforce context available to AI-driven workflows. The funding will support product and AI work to surface people-data insights across enterprise systems.
Reapit raised more than £20m from Accel‑KKR to accelerate AI and consumer-facing work on its property platform. The capital will back its Reapit Home portal and efforts to shift estate agents from one‑off transactions to ongoing customer relationships.
needi closed a £1m pre-seed from IFNI to scale its personalised corporate gifting and onboarding platform. The follow‑on investment will help the company expand product capabilities and support international sales.
Fintech and wealthtech: cloud partnerships drive platform modernisation
Fintech investors this week emphasised platform modernisation paired with strategic cloud partnerships. Backers are favouring businesses that combine recurring revenue with enterprise scale, and vendors are using capital plus cloud alliances to accelerate migration from incumbent infrastructure.
FNZ raised £332.74 million in a growth round and announced a strategic partnership with Microsoft to speed cloud migration and platform work for wealth managers. The combination of funding and a major cloud tie‑up is intended to accelerate product development and larger enterprise sales motions.
The broader lesson is that strategic partnerships matter as much as cash when serving regulated, enterprise customers; investors appear to prefer deals that reduce integration risk and signal a smoother path to adoption.
This week's Fintech & Wealthtech deals:
FNZ raised £332.74m in a growth round alongside a strategic partnership with Microsoft aimed at accelerating cloud migration and platform work for wealth managers. The capital and the cloud tie-up are intended to speed product development and enterprise sales.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.